These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 303995)

  • 21. Antimetastatic and growth-inhibitory effects of N-acetylchitohexaose in mice bearing Lewis lung carcinoma.
    Tsukada K; Matsumoto T; Aizawa K; Tokoro A; Naruse R; Suzuki S; Suzuki M
    Jpn J Cancer Res; 1990 Mar; 81(3):259-65. PubMed ID: 2112529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimetastatic effect of yeast mannan-bleomycin conjugate against mouse Lewis lung carcinoma.
    Konno Y; Takahashi S; Naruse R; Mikami T; Matsumoto T; Suzuki S; Suzuki M
    Biol Pharm Bull; 1994 May; 17(5):748-52. PubMed ID: 7522733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of antitumor and antimetastatic activity of pepstatin A in some experimental tumor models.
    Tumminello FM; Leto G; Gebbia N; Rausa L; Bernacki RJ
    J Chemother; 1989 Jul; 1(4 Suppl):1135-8. PubMed ID: 16315374
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel plasmin-inhibitor inhibits the growth of human tumor xenografts and decreases metastasis number.
    Szende B; Okada Y; Tsuda Y; Horvath A; Bökönyi G; Okamoto S; Wanaka K; Kéri G
    In Vivo; 2002; 16(5):281-6. PubMed ID: 12494864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levamisole inhibits and cures a solid malignant tumour and its pulmonary metastases in mice.
    Renoux G; Renoux M
    Nat New Biol; 1972 Dec; 240(102):217-8. PubMed ID: 4509143
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-induced inhibition of tumour cell dissemination.
    Burrage K; Hellmann K; Salsbury AJ
    Br J Pharmacol; 1970 May; 39(1):205P-206P. PubMed ID: 5420103
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunomodulating and antimetastatic activity of 3-(p-chlorophenyl) thiazolo[3,2-a]benzimidazole-2-acetic acid (Wy-18,251, NSC 310633).
    Fenichel RL; Alburn HE; Schreck PA; Bloom R; Gregory FJ
    J Immunopharmacol; 1980; 2(4):491-508. PubMed ID: 6970786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue.
    Algarra I; Pérez M; Höglund P; Gaforio JJ; Ljunggren HG; Garrido F
    Int J Cancer; 1993 May; 54(3):518-23. PubMed ID: 8509228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice.
    Giraldi T; Nisi C; Sava G
    J Natl Cancer Inst; 1977 Apr; 58(4):1129-30. PubMed ID: 403295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of aprotinin-induced enhancement of metastasis of Lewis lung tumors in mice.
    Turner GA; Weiss L
    Cancer Res; 1981 Jul; 41(7):2576-80. PubMed ID: 6166366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159.
    Hellmann K; James SE; Salsbury AJ
    Br J Cancer; 1974 Aug; 30(2):179. PubMed ID: 4419316
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor and other effects of 24R,25-dihydroxycholecalciferol in Lewis lung carcinoma causing abnormal calcium metabolism in tumor-bearing mice.
    Maeda Y; Yamato H; Hirai T; Kobori N; Fujii T; Kobayashi Y; Saitoh K; Inoguchi E; Hakozaki M; Iijima H
    Oncology; 1988; 45(3):202-5. PubMed ID: 3368196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimetastatic activities of synthetic Arg-Gly-Asp-Ser (RGDS) and Arg-Leu-Asp-Ser (RLDS) peptide analogues and their inhibitory mechanisms.
    Fujii H; Komazawa H; Mori H; Kojima M; Itoh I; Murata J; Azuma I; Saiki I
    Biol Pharm Bull; 1995 Dec; 18(12):1681-8. PubMed ID: 8787788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions.
    Nakajima M; Hayashi K; Katayama K; Amano Y; Egi Y; Uehata M; Goto N; Kondo T
    Eur J Pharmacol; 2003 Jan; 459(2-3):113-20. PubMed ID: 12524136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Proteolytic enzymes and their inhibitors in clinical and experimental oncology].
    Geshelin SA; Vovchuk SV; Blizniuk BF; Varbanets VF
    Vopr Onkol; 1984; 30(10):9-18. PubMed ID: 6208687
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective chemotherapy of cancer metastases with triton WR 1339.
    Franchi G; Garattini S
    Eur J Cancer (1965); 1971 Dec; 7(6):579-80. PubMed ID: 5143817
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma.
    Koldysheva EV; Men'shchikova AP; Lushnikova EL; Popova NA; Kaledin VI; Nikolin VP; Zakharenko AL; Luzina OA; Salakhutdinov NF; Lavrik OI
    Bull Exp Biol Med; 2019 Mar; 166(5):661-666. PubMed ID: 30903487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flat revertant inducers, styryl diphenylamine derivatives, inhibit growth and metastasis of murine tumor cells in vivo.
    Ohizumi I; Tanemura M; Tsunenari T; Sato K; Kozono T; Kaiho S
    Anticancer Res; 1997; 17(1A):393-400. PubMed ID: 9066683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental study of the antimetastatic activity of thaliblastin].
    Mircheva I
    Eksp Onkol; 1984; 6(2):48-9. PubMed ID: 6096114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.